| Literature DB >> 26483584 |
Robert McCorkell1, Shawn R Horsman1, Katherine Wynne-Edwards1, Greg Muench1, Sylvia van Drunen Littel-van den Hurk1, Regula Waeckerlin1, Michael Eschbaumer1, Rkia Dardari1, Mark Chaiyakul1, Pawel Gajda1, Markus Czub1, Frank van der Meer1.
Abstract
Immunosuppressive effects of an intranasal challenge with non-cytopathic bovine viral diarrhea virus (BVDV) 2a (strain 1373) were assessed through acquired and innate immune system responses to ovalbumin (OVA). Concurrent BVDV infection was hypothesized to delay and reduce the humoral response to ovalbumin (administered on days 3 and 15 post-inoculation). Infected animals followed the expected clinical course. BVDV titers, and anti-BVDV antibodies confirmed the course of infection and were not affected by the administration of OVA. Both the T-helper (CD4(+)) and B-cell (CD20(+)) compartments were significantly (P < 0.05) reduced in infected animals, while the gamma-delta T-cell population (Workshop cluster 1+, WC1(+)) decreased slightly in numbers. Infection with BVDV delayed the increase in OVA IgG by approximately 3 d from day 12 through day 21 post-inoculation. Between days 25 and 37 post-inoculation following BVDV infection the IgM concentration in the BVDV- group decreased while the OVA IgM titer still was rising in the BVDV+ animals. Thus, active BVDV infection delays IgM and IgG responses to a novel, non-infectious antigen.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26483584 PMCID: PMC4572827
Source DB: PubMed Journal: Can Vet J ISSN: 0008-5286 Impact factor: 1.008